voyager therapeutics aktie

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Voyager Therapeutics Aktie

Isin us92915b1061, symbol vygr, voyager therapeutics aktie chart.

Für Voyager Therapeutics ist der Dividenden-Chartvergleich verfügbar: Jetzt anzeigen

Der Dividenden-Chartvergleich zeigt die Rendite inklusive der Ausschüttungen (Aktienkurs + Dividende, grün) im Vergleich zum Aktienkurs (blau) und so die wirkliche Rendite einer Investition in die Aktie.

Dividende ausblenden

News & Videos

Aktuelle voyager therapeutics inc aktie news, analysen und kennzahlen, voyager therapeutics inc analysen.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Voyager Therapeutics Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Voyager Therapeutics Aktie Kennzahlen

Dividendenübersicht historische Bilanz Schätzungen

Kurse und Börsenplätze

Voyager therapeutics inc aktie deutsche börsenübersicht, voyager therapeutics times and sales (stuttgart), chartsignale, voyager therapeutics aktie chartsignale, voyager therapeutics inc aktie peergroup: chartsignal vergleich, passende wertpapiere zur voyager therapeutics aktie, peer group mit besserer jahres-performance, investierte fonds, über voyager therapeutics inc, voyager therapeutics inc aktie profil.

Die Voyager Therapeutics Inc Aktie wird unter der ISIN US92915B1061 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Berlin, NASDAQ, Bats, gettex, Tradegate, Lang & Schwarz und Baader Bank gehandelt. Voyager Therapeutics Inc ist ein Unternehmen aus den USA.

We couldn’t find any results matching your search.

Please try using other words for your search or explore other sections of the website for relevant information.

We’re sorry, we are currently experiencing some issues, please try again later.

Our team is working diligently to resolve the issue. Thank you for your patience and understanding.

Bid Price and Ask Price

The  bid  &  ask  refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. The numbers next to the bid/ask are the “ size ”. The bid size displays the total amount of desired shares ... Read More. to buy at that price, and the ask size is the number of shares offered for sale at that price. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. The  bid-ask spread  can indicate a stock’s liquidity, which is how easy it is to buy and sell in the marketplace. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. You can use the bid-ask spread to determine whether to place a  market order  or  limit order  when trading, helping you to optimize your price and have a successful order execution. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visit  Nasdaq Data Link's products page . ... Read Less.

• After-Hours
• Press Releases
• Analyst Research
• Dividend History
• Historical Quotes
• Historical NOCP
• P/E & PEG Ratios
• Option Chain
• Short Interest
• Institutional Holdings
• Insider Activity
• SEC Filings
• Revenue EPS

Symbol Search

Recently viewed.

Analyze your stocks, your way

Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.

Latest News

This data feed is not available at this time.

Trending Stocks

Trending etfs, trending indexes.

• Real-time Data is provided using Nasdaq Last Sale Data

Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at  data.nasdaq.com .

• Type a symbol or company name. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return.

These symbols will be available throughout the site during your session.

Your symbols have been updated

Edit watchlist.

• Type a symbol or company name. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return.

Opt in to Smart Portfolio

Smart Portfolio is supported by our partner TipRanks. By connecting my portfolio to TipRanks Smart Portfolio I agree to their Terms of Use .

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources. Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Voyager Therapeutics Inc

Ever heard of finviz*elite.

Our premium service offers you real-time quotes, advanced visualizations, technical studies, and much more. Become Elite and make informed financial decisions.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

trading higher

Voyager Therapeutics Inc

Key statistics.

1.70 mean rating - 10 analysts

2024 (millions USD)

About Voyager Therapeutics Inc (VYGR.OQ)

Company information.

Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs, all of which are in preclinical development, include Anti-Tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy Program, Tau Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program, and others. VY-TAU01 is for the treatment of Alzheimer’s disease. SOD1 Silencing Gene Therapy Program is for the treatment of ALS.

Contact Information

+ 1 ( 857 ) 2595340

https://www.voyagertherapeutics.com/

Biotechnology & Drugs

Executive Leadership

Income statement.

2023 (millions USD)

Balance Sheet

Source: LSEG New Tab , opens new tab - data delayed by at least 15 minutes

Markets Performance

Commodities chevron, currencies chevron, rates & bonds chevron, stocks chevron.

English (USA)

English (UK)

English (Canada)

English (India)

Deutsch (Deutschland)

Deutsch (Österreich)

Deutsch (Schweiz)

Français (France)

Français (Suisse)

Nederlands (Nederland)

Nederlands (België)

• Top Capitalization
• United States
• North America
• Middle East
• Sector Research
• Earnings Calendar
• Equities Analysis
• Most popular
• TESLA, INC.
• DEUTSCHE BANK AG
• NIPPON ACTIVE VALUE FUND PLC
• MICROSOFT CORPORATION
• Index Analysis
• Indexes News
• EURO STOXX 50
• Currency Cross Rate
• Currency Converter
• Forex Analysis
• Currencies News
• Precious metals
• Agriculture
• Industrial Metals
• Livestock and Cattle
• CRUDE OIL (WTI)
• CRUDE OIL (BRENT)

• Developed Nations
• Emerging Countries
• South America
• Analyst Reco.
• Capital Markets Transactions
• New Contracts
• Profit Warnings
• Appointments
• Press Releases
• Security Transactions
• Earnings reports
• New markets
• New products
• Corporate strategies
• Legal risks
• Share buybacks
• Mergers and acquisitions
• Call Transcripts
• Currency / Forex
• Commodities
• Cryptocurrencies
• Interest Rates
• Asset Management
• Climate and ESG
• Cybersecurity
• Geopolitics
• Central Banks
• Private Equity
• Business Leaders
• All our articles
• Most Read News
• All Analysis
• Satirical Cartoon
• Today's Editorial
• Crypto Recap
• Behind the numbers
• All our investments
• Asia, Pacific
• Virtual Portfolios
• USA Portfolio
• European Portfolio
• Asian Portfolio
• My previous session
• My most visited
• Multibaggers
• Growth stocks at reasonable prices
• Undervalued stocks
• Growth stocks
• Momentum stocks
• Digital Health and Telemedicine
• Europe's family businesses
• E-Commerce & Logistics
• Millennials
• Unusual volumes
• New Historical Highs
• New Historical Lows
• Top Fundamentals
• Sales growth
• Earnings Growth
• Profitability
• Rankings Valuation
• Enterprise value
• Top Consensus
• Analyst Opinion
• Target price
• Estimates Revisions
• Top ranking ESG
• Environment
• Visibility Ranking
• Stock Screener Home
• Ageing Population
• 3D Printing
• Place your bets
• Wind energy
• Oversold stocks
• Overbought stocks
• Close to resistance
• Close to support
• Accumulation Phases
• Most volatile stocks
• Top Investor Rating
• Top Trading Rating
• Top Dividends
• Low valuations
• All my stocks
• Stock Screener
• Stock Screener PRO
• Portfolio Creator
• Event Screener
• Dynamic Chart
• Economic Calendar
• ProRealTime Trading
• Our subscriptions
• Our Stock Picks
• Thematic Investment Lists

Voyager Therapeutics, Inc. Stock

Us92915b1061, biotechnology & medical research, financials (usd), chart voyager therapeutics, inc., latest news about voyager therapeutics, inc., latest transcript on voyager therapeutics, inc..

Analyst Recommendations on Voyager Therapeutics, Inc.

Press releases voyager therapeutics, inc., news in other languages on voyager therapeutics, inc., quotes and performance, highs and lows.

Managers and Directors - Voyager Therapeutics, Inc.

Etfs positioned on voyager therapeutics, inc..

Delayed Quote Nasdaq, April 29, 2024 at 10:57 am EDT

Company Profile

Income statement evolution, ratings for voyager therapeutics, inc., analysts' consensus, eps revisions, quarterly earnings - rate of surprise, sector other biotechnology & medical research.

• Stock Market

Vision, Mission, & Strategy

Management Team

Board of Directors

Scientific Advisory Board

• VY-TAU01 for Alzheimer’s

• Alzheimer’s early research

• SOD1 for ALS

Patient Resources

Partnerships

TRACER Platform

Non-Viral Approaches

Publications & Presentations

Press Releases

Events & Presentations

Corporate Governance

Stock Information

Job Openings

Our Community

Core Values

Disclosures

Shareholder Services

Latest News

Voyager Therapeutics to Present Broad Set of Translational Data Supporting...

Voyager Therapeutics Announces Selection of Development Candidate for GBA1...

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule...

Voyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases.

Advancing transformative medicines for neurological diseases.

Our pipeline includes genetic medicines for Alzheimer’s disease , amyotrophic lateral sclerosis (ALS) , Parkinson’s disease , and multiple other diseases of the central nervous system.

Revolutionizing delivery across the blood-brain barrier.

Our people are our most valuable resource.

We are looking for dedicated professionals who share our passion for advancing transformative neurogenetic medicines.